Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. May 16, 2022; 10(14): 4528-4534
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4528
Table 1 Clinical features of patients with coexisting disseminated superficial actinic porokeratosis and porokeratosis ptychotropica
Ref.
Gender
Age
Ethnicity
Nationality
Clinical variants
Genetics
Risk factors
Treatment
Thomas et al[21]Female78 yrNAUnited KingdomDSAP, PptNANoneNA
McGuigan et al[7]Male84 yrNAUnited StatesDSAP, PptNASun exposure, non-melanoma skin cancer0.025% tretinoin cream, 0.05% tazarotene cream.
Murase et al[22]Female73 yrKoreanKoreaDSAP, Ppt linear porokeratosisNAFamily historyNA
Peng et al[23]Male70 yrChineseChinaDSAP, PptMVK missense mutation (c.1039G>C, p.Gl- y347Arg)Family historyOral acitretin (20 mg daily)
Our patientMale45 yrChineseChinaDSAP, PptMVK missense mutation (c.155G>A, p.Ser52Asn)Family historyMicrowave knife